0
Skip to Content
Veravas
Tau Pathology
Clinicians
Celiac Disease
Lyme Disease
Neurodegenerative Disease
VeraBIND Technology
Patients
Payers
Early Detection
VeraBIND Tau Assay
Researchers
VeraBIND Technology
Clean Beads
Streptavidin Beads for Free Biotin Depletion
Streptavidin Beads Protein Coating Kit
Biomarker Purification Kit
Antibody Detection Kit
Borrelia Antibody Assay
tTG Antibody Assay
Resources
About
Leadership
Contact Us
News
Events
Veravas
Tau Pathology
Clinicians
Celiac Disease
Lyme Disease
Neurodegenerative Disease
VeraBIND Technology
Patients
Payers
Early Detection
VeraBIND Tau Assay
Researchers
VeraBIND Technology
Clean Beads
Streptavidin Beads for Free Biotin Depletion
Streptavidin Beads Protein Coating Kit
Biomarker Purification Kit
Antibody Detection Kit
Borrelia Antibody Assay
tTG Antibody Assay
Resources
About
Leadership
Contact Us
News
Events
Tau Pathology
Folder: Clinicians
Back
Celiac Disease
Lyme Disease
Neurodegenerative Disease
VeraBIND Technology
Patients
Folder: Payers
Back
Early Detection
VeraBIND Tau Assay
Folder: Researchers
Back
VeraBIND Technology
Clean Beads
Streptavidin Beads for Free Biotin Depletion
Streptavidin Beads Protein Coating Kit
Biomarker Purification Kit
Antibody Detection Kit
Borrelia Antibody Assay
tTG Antibody Assay
Resources
Folder: About
Back
Leadership
Contact Us
News
Events
Shop All Products COVID-19 Saliva Antibody Test
Box Mockup.jpg Image 1 of
Box Mockup.jpg
Box Mockup.jpg

COVID-19 Saliva Antibody Test

$159.00

Is your body producing neutralizing antibodies against SARS-Cov-19?

The VERAVAS COVID-19 Antibody Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

Using our proprietary antibody detection platform, Veravas developed a quantitative antibody test to detect IgG, IgA, and IgM antibodies to SARS-CoV-2 in a Swish-N-Spit (saliva-based) sample.

Quantity:
Add To Cart

Is your body producing neutralizing antibodies against SARS-Cov-19?

The VERAVAS COVID-19 Antibody Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

Using our proprietary antibody detection platform, Veravas developed a quantitative antibody test to detect IgG, IgA, and IgM antibodies to SARS-CoV-2 in a Swish-N-Spit (saliva-based) sample.

Is your body producing neutralizing antibodies against SARS-Cov-19?

The VERAVAS COVID-19 Antibody Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

Using our proprietary antibody detection platform, Veravas developed a quantitative antibody test to detect IgG, IgA, and IgM antibodies to SARS-CoV-2 in a Swish-N-Spit (saliva-based) sample.

veravas-logo-white.png

Corporate Headquarters
111 Congress Avenue
Suite 500
Austin, TX 78701

Research & Development
3510 Hopkins Place N
Oakdale, MN 55128

Contact
Phone: (512) 837-2827
Email: info@veravas.com

© 2024 Veravas, Inc. | Privacy | Investors | Terms & Conditions